The No Surprises Act is largely working as intended to protect patients from unexpected medical bills. However, the rising number of Independent Dispute Resolution (IDR) cases is creating challenges for the health care system. In a post for Health Affairs Forefront, Jack Hoadley and Kevin Lucia evaluate the causes and implications of the increasing number of IDR cases.
As the number of opioid-related overdose fatalities remains alarmingly high, access to medication-assisted treatment (MAT) is inconsistent. Private insurance does not always cover the full range of MAT options, and when it does provide coverage cost sharing can be prohibitive. CHIR’s Rachel Swindle takes a look at state and federal reforms that can help lessen private insurance related barriers to treatment.
Blue Cross Blue Shield of Mississippi has included a new provision in its plan description that could mean huge costs for plan participants. The new policy does not cover prescription drugs prescribed by out-of-network providers. How does this policy square with the ACA? And what does it mean for consumers? Elissa Dines discusses.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
